ARGENX SE DRN revenue breakdown overview

ARGENX SE DRN revenue for the last year amounted to 13.88 B BRL, the most of which — 13.00 B BRL — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 6.09 B BRL. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENX SE DRN 11.25 B BRL, and the year before that — 5.34 B BRL.